Loading...
•
Dec 31, 2019
Amphastar Q4 2019 Earnings Report
Reported net revenues of $83.4 million and a GAAP net loss of $1.0 million for the fourth quarter.
Key Takeaways
Amphastar Pharmaceuticals reported net revenues of $83.4 million for the fourth quarter ended December 31, 2019. The company's GAAP net loss was $1.0 million, or $(0.02) per share, while adjusted non-GAAP net income was $3.6 million, or $0.07 per share.
Net revenues for the fourth quarter were $83.4 million.
GAAP net loss for the fourth quarter was $1.0 million, or $(0.02) per share.
Adjusted non-GAAP net income for the fourth quarter was $3.6 million, or $0.07 per share.
Primatene® Mist sales were strong, equaling sales in the previous three quarters combined.
Revenue by Segment
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...